Skip to content

Clinical trials

Phase 3 Atrial Fibrillation trials in Argentina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Country / region: Argentina Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20043
20053
20062
20073
20082
20101
20131
20141
20181
20211
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated4
Active, not recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi7
Astellas Pharma Inc3
Boehringer Ingelheim2
Bristol-Myers Squibb2
Anthos Therapeutics, Inc.1
AstraZeneca1
Bayer1
CSL Behring1
Daiichi Sankyo1
Fundacion GESICA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation24
Atrial Flutter6
Stroke5
Arrhythmias, Cardiac3
Cardiovascular Diseases2
Embolism2
Acute Coronary Syndrome1
Atherosclerosis1
Coronary Artery Disease1
Heart Diseases1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.